Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation

J Neurosci Res. 2016 Feb;94(2):111-3. doi: 10.1002/jnr.23696. Epub 2015 Nov 17.

Authors

Abolfazl Shakeri¹, Amirhossein Sahebkar^{2

3}

Affiliations

¹ Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
² Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
³ Metabolic Research Centre, School of Medicine and Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, Western Australia, Australia.

PMID: 26577706
DOI: 10.1002/jnr.23696

No abstract available

Keywords: Alzheimer's disease; bioavailability; cognition; curcumin; dementia; formulation; phytochemical.

MeSH terms

Alzheimer Disease / drug therapy*
Animals
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Curcumin / therapeutic use*
Humans
Middle Aged
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Curcumin